SCHEDULE: Capital Research Global Investors Discloses 3.5% Stake
Beneficial Ownership Report
Capital Research Global Investors has disclosed a 3.5% beneficial ownership stake in Establishment Labs Holdings Inc., holding 1,024,417 common shares.
Summary
- Capital Research Global Investors (CRGI) reported beneficial ownership of 1,024,417 shares of common stock in Establishment Labs Holdings Inc.
- This stake represents 3.5% of the issuer's common stock, based on 28,917,254 shares believed to be outstanding.
- CRGI, a division of Capital Research and Management Company, holds sole voting and dispositive power over all 1,024,417 shares.
- The filing is an Amendment No. 2 to a previous Schedule 13G, indicating an update to their ownership position.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 7
Explanation: The disclosure of a significant beneficial ownership stake by a major institutional investor like Capital Research Global Investors generally indicates confidence in the company's long-term prospects and stability.
Positives
- The disclosure of a significant beneficial ownership stake by a major institutional investor like Capital Research Global Investors can signal confidence in the issuer's long-term prospects and stability.
Future Outlook
NA
Industry Context
This filing indicates an institutional investor's position in Establishment Labs Holdings Inc., a company known for its medical aesthetics products, specifically breast implants. Such disclosures are common in the medical device and healthcare sectors as large investment firms adjust their portfolio holdings.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake can influence market perception, potentially increasing investor confidence and liquidity for the stock.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 08/05/2025 | Signature date of the filing |
Keywords
Establishment Labs Holdings Inc., Capital Research Global Investors, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Schedule 13G, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.